SCHOLARLY PUBLICATION ✓ Open Access

PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project

Ming‐Sound Tsao, Keith M. Kerr, Mark M. Kockx, Mary Beth Beasley, Alain Borczuk, Johan Botling, Lukas Bubendorf, Lucian R. Chirieac, Gang Chen, Teh‐Ying Chou, Jin-Haeng Chung, Sanja Đačić, Sylvie Lantuéjoul, Mari A. Mino-Kenudson, Andre Luis Moreira, Andrew Gordon Nicholson, Masayuki Noguchi, Giuseppe Pelosi, Claudia Poleri, Prudence Anne Russell, Jennifer L. Sauter, Erik Thunnissen, Ignacio Ivan Wistuba, Hui Yu, Murry W. Wynes, Melania Pintilie, Yasushi Yatabe, Fred R. Hirsch

📖 Journal of Thoracic Oncology → 📅 2018-05-22 🔗 DOI: 10.1016/j.jtho.2018.05.013

View Journal Profile → ⬇ Download PDF View Official Paper ↗

📄 Abstract

The abstract has not yet been added. Use the official source link for the complete publication record.

ℹ️ Publication Details

Journal: Journal of Thoracic Oncology
Published: 2018-05-22
DOI: 10.1016/j.jtho.2018.05.013
OpenAlex: W2804957255
Access: ✓ Open Access

📄 Abstract

🔬 Related Research Papers

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial

Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC—an Update From the PACIFIC Trial

Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Study

IMpower150 Final Overall Survival Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial

The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer

The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends

Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis

Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study

The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer

PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project